Celestial Biolabs Financials

NSE: CELESTIAL | BSE: 532871

₹1.75

₹-0.05 (-2.78%)

As on 11-Mar-2020IST

Market cap

₹5 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

P/B Ratio

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19
Operating Revenue	0.13	0.17	0.15	--	--	--
Total Income	0.13	0.17	0.15	--	--	--
Total Expenditure	0.52	0.71	0.49	--	--	--
EBITDA	-0.38	-0.54	-0.34	--	--	--
Depreciation	0.02	0.03	0.03	--	--	--
EBIT	-0.41	-0.57	-0.37	--	--	--
Interest	0.01	0.01	0.04	--	--	--
Other Income	--	--	--	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.41	-0.58	-0.41	--	--	--
Provision for Tax	--	--	--	--	--	--
Profit after Tax	-0.41	-0.58	-0.41	--	--	--
Minority Interest	0.01	0.00	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	-0.41	-0.58	-0.41	--	--	--

Liabilities (₹ Cr)	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19
Shareholder's Funds	2.64	2.77	3.35	--	--	--
Minority Interest	0.01	0.00	--	--	--	--
Non-Current Liabilities	8.99	8.98	8.49	--	--	--
Current Liabilities	5.56	5.49	5.34	--	--	--
Total Liabilities	17.18	17.24	17.18	--	--	--

Assets (₹ Cr)	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19
Non-Current Assets	12.89	12.90	12.92	--	--	--
Current Assets	4.30	4.34	4.26	--	--	--
Total Assets	17.18	17.24	17.18	--	--	--
Total Debt*	--	12.03	11.54	--	--	--
Net Current Assets	-1.26	-1.15	-1.08	--	--	--
Contingent Liabilities	--	1.29	1.29	--	--	--

Cashflow (₹ Cr)	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19
Cash From Operating Activities	--	-0.36	-0.28	--	--	--
Cash Flow from Investing Activities	--	-0.01	0.00	--	--	--
Cash from Financing Activities	--	0.38	0.26	--	--	--
Net Cash Inflow / Outflow	--	0.01	-0.02	--	--	--

Financials Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19
Adjusted EPS (₹)	-0.18	-0.26	-0.18	--	--	--
Cash EPS (₹)	--	-0.24	-0.17	--	--	--
Adjusted Book Value (₹)	--	1.23	1.48	--	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-0.16	-0.12	--	--	--
Free Cash Flow per Share (₹)	--	-0.16	-0.12	--	--	--

Profitability Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19
ROCE (%)	--	-3.86	-2.47	--	--	--
ROE (%)	-15.00	-18.99	-12.22	--	--	--
ROA (%)	-4.82	-3.38	-2.38	--	--	--
EBIT Margin (%)	-302.99	-339.72	-249.69	--	--	--
Net Margin (%)	-308.96	-344.64	-277.63	--	--	--
Cash Profit Margin (%)	0.00	-327.86	-257.15	--	--	--

Growth Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19
Revenue Growth (%)	-30.93	14.37	--	--	--	--
EBIT Growth (%)	33.44	-55.61	--	--	--	--
Net Profit Growth (%)	34.64	-41.98	--	--	--	--
EPS Growth (%)	34.65	-40.82	--	--	--	--
Book Value Growth (%)	--	-17.21	--	--	--	--

Valuation Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.05	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.36	-63.50	-100.93	--	--	--
Close Price (₹)	--	--	--	--	--	--
High Price (₹)	--	--	--	--	--	--
Low Price (₹)	--	--	--	--	--	--
Market Cap (₹ Cr)	4.56	--	--	--	--	--

Solvency Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19
Debt to Equity	3.40	4.34	3.44	--	--	--
Short term debt to equity ratio	--	1.10	0.91	--	--	--
Current Ratio	0.77	0.79	0.80	--	--	--
Quick Ratio	0.77	0.78	0.79	--	--	--
Interest Coverage	-50.75	-69.05	-8.94	--	--	--

Operating Efficiency Ratios	TTM	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19
Debtors to sales (%)	2,738.06	2,197.75	2,598.51	--	--	--
Asset Turnover	0.02	0.01	0.01	--	--	--
Receivable days	--	8,157.22	9,484.56	--	--	--
Inventory Days	--	89.36	120.76	--	--	--
Payable days	--	1,398.94	1,528.77	--	--	--
Cash Conversion Cycle	--	6,847.64	8,076.55	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)